Literature DB >> 10995598

Insulin sensitivity of glucose and fat metabolism in severe sepsis.

C Chambrier1, M Laville, M Odeon, P Boulétreau, M Beylot.   

Abstract

In order to quantify the changes in insulin sensitivity, particularly of endogenous glucose production and fat metabolism, in patients with severe sepsis, a prospective study was conducted in five normal subjects and in five patients with severe sepsis hospitalized in an intensive care unit. The responses of endogenous glucose production, glucose utilization, plasma fatty acids and ketone body concentrations to progressive increase in plasma insulin levels (exogenous insulin infusion rates of 0, 0.5, 1 and 2 m-units x min(-1) x kg(-1)) were measured using the isoglycaemic clamp technique. Total glucose turnover was determined with D-[6,6-(2)H(2)]glucose. In each group, plasma glucose was maintained at basal levels (control subjects, 4.32+/-0.22 mmol x l(-1); patients with sepsis, 7.10+/-2.29 mmol x l(-1); P<0.05). Plasma insulin concentrations were comparable in the two groups at an insulin infusion rate of 0.4 m-unit x min(-1) x kg(-1) for controls and 0.5 m-unit x min(-1) x kg(-1) for patients with sepsis, but differed following infusion at 2 m-unit x min(-1) x kg(-1) (control subjects, 102+/-13.4 m-units x l(-1); patients with sepsis, 124.8+/-19.7 m-units x l(-1); P<0.05). Endogenous glucose production was completely suppressed in control subjects by the first insulin infusion (0.4 m-unit x min(-1) x kg(-1)), but was only suppressed during infusion at 1 m-unit x min(-1) x kg(-1) insulin in patients with sepsis. The glucose utilization rate increased significantly with exogenous insulin infusion in control subjects, but did not increase in patients with sepsis. Plasma non-esterified (free) fatty acid and ketone body levels were significantly decreased in both groups by the infusion of exogenous insulin, but the sensitivity of lipolysis was impaired in patients with sepsis. In conclusion, sepsis impaired to a varying extent the action of insulin on endogenous glucose production, glucose utilization, lipolysis and ketogenesis. Whole-body glucose uptake was the most affected, with a total lack of response to the elevated insulin levels obtained in this study. Suppression of endogenous glucose production and lipolysis could only be achieved with higher doses of insulin than those required in normal subjects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995598

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  18 in total

1.  Estimating Increased EGP During Stress Response in Critically Ill Patients.

Authors:  Jennifer J Ormsbee; Jennifer L Knopp; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2020-06-01

2.  Parenteral glucose and glucose control in the critically ill: a kinetic appraisal.

Authors:  Roman Hovorka; Jeremy Cordingley
Journal:  J Diabetes Sci Technol       Date:  2007-05

Review 3.  Response to trauma and metabolic changes: posttraumatic metabolism.

Authors:  Turgay Şimşek; Hayal Uzelli Şimşek; Nuh Zafer Cantürk
Journal:  Ulus Cerrahi Derg       Date:  2014-09-01

4.  Dynamic change of glycemic status during the early phase after allogeneic hematopoietic stem cell transplantation.

Authors:  S Fuji; K Yakushijin; S-W Kim; K Yoshimura; S Kurosawa; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2015-07-13       Impact factor: 5.483

5.  Model-based insulin sensitivity as a sepsis diagnostic in critical care.

Authors:  Amy Blakemore; Sheng-Hui Wang; Aaron Le Compte; Geoffrey M Shaw; Xing-Wei Wong; Jessica Lin; Thomas Lotz; Christopher E Hann; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2008-05

6.  Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet.

Authors:  Nishanth E Sunny; Santhosh Satapati; Xiaorong Fu; TianTeng He; Roshi Mehdibeigi; Chandra Spring-Robinson; Joao Duarte; Matthew J Potthoff; Jeffrey D Browning; Shawn C Burgess
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-16       Impact factor: 4.310

7.  A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle.

Authors:  Hannah Crossland; Dumitru Constantin-Teodosiu; Sheila M Gardiner; Despina Constantin; Paul L Greenhaff
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

Review 8.  Stress-hyperglycemia, insulin and immunomodulation in sepsis.

Authors:  Paul E Marik; Murugan Raghavan
Journal:  Intensive Care Med       Date:  2004-02-26       Impact factor: 17.440

Review 9.  Bench-to-bedside review: Glucose and stress conditions in the intensive care unit.

Authors:  Marie-Reine Losser; Charles Damoisel; Didier Payen
Journal:  Crit Care       Date:  2010-08-20       Impact factor: 9.097

Review 10.  Bench-to-bedside review: Beta-adrenergic modulation in sepsis.

Authors:  Etienne de Montmollin; Jerome Aboab; Arnaud Mansart; Djillali Annane
Journal:  Crit Care       Date:  2009-10-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.